BAC
Bank of America Corporation
BAC's outlook is improving, though it still trails on the overall score.
NTRS
Northern Trust Corporation
NTRS has the edge over BAC overall, supported by stronger fundamentals and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NTRS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
NTRS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like NTRS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
NTRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $155 | -13% |
| Current | 14x | $178 | — |
| Forward | 14x | $178 | — |
| Fair | 15x | $188 | +6% |
| Expensive | 18x | $235 | +32% |
Historical ranges are pointers, not guarantees.
NTRS has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over NTRS on the outlook, with more favorable valuation and revenue expectations.
NTRS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect NTRS's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
NTRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.59 | -1.3% |
| Q3 2026 | $12.76 | +49% |
| Q2 2026 | $11.65 | +37% |
| Q1 2026 | $9.55 | -11% |
| Q4 2025 | $8.74 | -11% |
| Q3 2025 | $8.57 | +6.6% |
| Q2 2025 | $8.50 | +16% |
| Q1 2025 | $10.71 | +136% |
| Q4 2024 | $9.77 | +92% |
NTRS earned $12.76 per share over the past year, up 49% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
NTRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +13% |
| Q2 2026 | $2.7B | +35% |
| Q1 2026 | $2.2B | +14% |
| Q4 2025 | $2.1B | +8.3% |
| Q3 2025 | $2B | +2.9% |
| Q2 2025 | $2B | -26% |
| Q1 2025 | $1.9B | +18% |
| Q4 2024 | $2B | +27% |
NTRS's revenue is recovering but still below its 2024 peak: $2.3B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +4.1 points |
| Q2 2026 | 39% | +11 points |
| Q1 2026 | 32% | +4.9 points |
| Q4 2025 | 30% | -0.5 points |
| Q3 2025 | 31% | +0.1 points |
| Q2 2025 | 28% | -15 points |
| Q1 2025 | 27% | +9.2 points |
| Q4 2024 | 30% | +21 points |
NTRS has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over NTRS on cash flow, with more consistent year-over-year improvement.
NTRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.8B | +254% |
| Q2 2026 | -$90.3M | -105% |
| Q1 2026 | -$329.4M | -112% |
| Q4 2025 | $355.6M | +$3B |
| Q3 2025 | $509.4M | -13% |
| Q2 2025 | $1.9B | -37% |
| Q1 2025 | $2.7B | +$4.2B |
| Q4 2024 | -$2.7B | -198% |
NTRS's free cash flow was $1.7B over the past year, down 28% from the year before. Free cash flow isn't a meaningful measure for financial services companies like NTRS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NTRS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NTRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -1.7M shares |
| 1 year | -4.1% | -7.8M shares |
| 3 years | -12% | -24.1M shares |
| 5 years | -12% | -25.7M shares |
| Available history | -15% | -32.4M shares |
NTRS has 183M diluted shares, down 4.1% from a year ago, with $1.4B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $352.3M |
| Q2 2026 | $350.6M |
| Q1 2026 | $358.9M |
| Q4 2025 | $369.9M |
| Q3 2025 | $277M |
| Q2 2025 | $339.4M |
| Q1 2025 | $287.2M |
| Q4 2024 | $253.6M |
NTRS spent $1.4B buying back its own shares over the past year, up 24% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NTRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 2.0x | Healthy |
NTRS has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NTRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 37.9 | Neutral |
NTRS's weekly RSI is 56 (neutral) and its Stochastic is 38 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over NTRS on valuation relative to its sector.
NTRS PE vs Financial Services Sector
| Metric | NTRS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 7% above |
| PE % | 42 | 63 | 21 pts below |
NTRS is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NTRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $171.1 | 3.9% above |
| 20 week MA | $178.9 | 0.7% below |
| 50 week MA | $162.4 | 9.4% above |
| 100 week MA | $138.6 | 28% above |
| 200 week MA | $111.2 | 60% above |
NTRS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
NTRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $107.0 | $91.6 | -14% |
| 2021 | $91.6 | $118.2 | +29% |
| 2022 | $118.2 | $88.0 | -26% |
| 2023 | $88.0 | $84.4 | -4.1% |
| 2024 | $84.4 | $103.8 | +23% |
| 2025 | $103.8 | $140.1 | +35% |
| 2026 YTD | $140.1 | $177.7 | +27% |
NTRS has the edge over BAC on returns for 2026, with the stronger performance.